Opendata, web and dolomites

AGEMEC SIGNED

Age-dependent mechanisms of sporadic Alzheimer’s Disease in patient-derived neurons

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AGEMEC project word cloud

Explore the words cloud of the AGEMEC project. It provides you a very rough idea of what is the project "AGEMEC" about.

manner    suggests    conversion    mature    de    ad    switch    preserves    epigenetic    ultimate    direct    contrast    preliminary    shows    fibroblasts    treatment    opens    human    pathology    signatures    treatable    model    explore    risk    patient    mild    majority    agnostic    fail    models    serotonergic    disease    diseases    combine    exclusively    glutamatergic    impairment    link    malfunction    ins    assays    metabolome    differentiated    mci    started    strategies    glycolysis    neuronal    mechanisms    profiling    connection    cancer    links    cognitive    harness    aging    interface    surprisingly    age    dependent    interesting    spec    neuroscience    neuropsychiatric    people    alzheimer    patients    probably    data    metabolite    permitting    mechanistic    elusive    appear    sporadic    aerobic    contribution    overwhelming    profound    signature    metabolic    neurons    cellular    anticipate    ipsc    illuminate    accounts    understand    transcriptome    manipulating    regulators    earliest    mass    landscape    differentiation    avenues    first    discovered   

Project "AGEMEC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAET INNSBRUCK 

Organization address
address: INNRAIN 52
city: INNSBRUCK
postcode: 6020
website: http://www.uibk.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 1˙499˙565 €
 EC max contribution 1˙499˙565 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2025-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAET INNSBRUCK AT (INNSBRUCK) coordinator 1˙499˙565.00

Map

 Project objective

Sporadic Alzheimer’s Disease (AD) accounts for the overwhelming majority of all AD cases and exclusively affects people at old age. However, mechanistic links between aging and AD pathology remain elusive. We recently discovered that in contrast to iPSC models, direct conversion of human fibroblasts into induced neurons (iNs) preserves signatures of aging, and we have started to develop a patient-based iN model system for AD. Our preliminary data suggests that AD iNs show a neuronal but de-differentiated transcriptome signature. In this project, we first combine cellular neuroscience assays and epigenetic landscape profiling to understand how neurons in AD fail to maintain their fully mature differentiated state, which might be key in permitting disease development. Next, using metabolome analysis including mass spec metabolite assessment, we explore a profound metabolic switch in AD iNs that shows surprisingly many aspects of aerobic glycolysis observed also in cancer. While this link might represent an interesting connection between two age-dependent and de-differentiation-associated diseases, it also opens new avenues to harness knowledge from the cancer field to better understand sporadic AD. We further focus on identifying and manipulating key metabolic regulators that appear to malfunction in an age-dependent manner, with the ultimate goal to define potential targets and treatment strategies. Finally, we will focus on early AD mechanisms by extending our model to mild cognitive impairment (MCI) patients. An agnostic transcriptome and epigenetic landscape approach of glutamatergic and serotonergic iNs will help to determine the earliest and probably most treatable disease mechanisms of AD, and to better understand the contribution of neuropsychiatric risk factors. We anticipate that this project will help to illuminate the mechanistic interface of cellular aging and the development of AD, and help to define new strategies for AD.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AGEMEC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AGEMEC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PArtCell (2020)

Physiologically Crowded Artificial Cells for Relevant Drug Screens

Read More  

3DPBio (2020)

Computational Models of Motion for Fabrication-aware Design of Bioinspired Systems

Read More  

MINGRAFT (2020)

Biomineralizing coatings for maxillofacial implants

Read More  
lastchecktime (2020-10-31 9:34:32) correctly updated